This list is an analysis based on recent market events. It's not an investment recommendation.
About
ChitogenX Inc. is a biologics firm focused on orthopedic and sports medicine, committing its efforts to pioneering novel soft tissue repair technologies. The company's primary objective is to elevate the efficacy of sports medicine surgical procedures through its research and development. Its developmental pipeline includes a range of specialized products: Ortho-R, a specific formulation designed for rotator cuff injuries; Ortho-M, a biopolymer addressing meniscus repair; Ortho-C, another biopolymer for the regeneration of articular cartilage; and Ortho-V, a biopolymer developed to facilitate the healing of osteoarthritis. Additionally, they are advancing ORTHO-T, a biopolymer formulation engineered for tendon healing and regeneration. Previously known as Ortho Regenerative Technologies Inc., the company adopted its current name, ChitogenX Inc., in September of 2022. Established in 2015, ChitogenX maintains its headquarters in Kirkland, Canada.
The current price of CHNXF is $0.01 USD — it has decreased by -0% in the past 24 hours. Watch ChitogenX stock price performance more closely on the chart.
What is ChitogenX stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange ChitogenX stocks are traded under the ticker CHNXF.
Is ChitogenX stock price growing?▼
CHNXF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year ChitogenX has showed a +586.36% increase.
What is ChitogenX market cap?▼
Today ChitogenX has the market capitalization of 627,623.95
What is ChitogenX revenue for the last year?▼
ChitogenX revenue for the last year amounts to 0 USD.
What is ChitogenX net income for the last year?▼
CHNXF net income for the last year is -1.14M USD.
How many employees does ChitogenX have?▼
As of July 17, 2026, the company has 5 employees.
In which sector is ChitogenX located?▼
ChitogenX operates in the Health & Wellness sector.